|
|
|
|
D-20761
A synthetic luteinizing hormone-releasing hormone (LH-RH) antagonist that suppresses LH and sex steroid levels. (National Cancer Institute)
[an error occurred while processing this directive]
Additional Resources on D-20761 from the National Cancer Institute
Cancer.gov - Dictionary Also called dilatation and curettage. D-20761 A synthetic luteinizing hormone-releasing
hormone (LH-RH) antagonist that suppresses LH and sex steroid levels. ...
|
|
|